The ProtecT trial: Analysis of the patient cohort, baseline risk stratification and disease progression

<p><strong>Objective:</strong><br /> To test the hypothesis that the baseline clinico‐pathological features of the men with localized prostate cancer (PCa) included in the ProtecT (Prostate Testing for Cancer and Treatment) trial who progressed (n = 198) at a 10‐year median f...

Full description

Bibliographic Details
Main Authors:	Young, GJ, Davis, M, Turner, EL, Martin, RM, Goepel, JR, Varma, M, Griffiths, DF, Grigor, K, Mayer, N, Warren, AY, Bhattarai, S, Dormer, J, Mason, M, Staffurth, J, Walsh, E, Rosario, DJ, Catto, JW, Neal, DE, Donovan, JL, Hamdy, FC, Bollina, P, Doble, A, Doherty, A, Gillatt, D, Gnanapragasam, V, Hughes, O, Kockelbergh, R, Kynaston, H, Paul, A, Paez, E, Rowe, E
Other Authors:	Protect Study Group
Format:	Journal article
Language:	English
Published:	Wiley 2020

The ProtecT trial: Analysis of the patient cohort, baseline risk stratification and disease progression

Similar Items